Kim MH - Search Results

1

Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors.

Joo KM, Song SY, Park K, Kim MH, Jin J, Kang BG, Jang MJ, Lee GS, Kim MS, Nam DH. Joo KM, et al. Among authors: kim ms, kim mh. Int J Oncol. 2008 Oct;33(4):705-12. Int J Oncol. 2008. PMID: 18813783

2

Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib.

Nam DH, Park K, Park C, Im YH, Kim MH, Lee S, Hong SC, Shin HJ, Kim JH, Eoh W, McDonnell TJ. Nam DH, et al. Among authors: kim mh, kim jh. Oncol Rep. 2004 Feb;11(2):263-8. Oncol Rep. 2004. PMID: 14719052

3

Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.

Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH. Son MJ, et al. Among authors: kim h, kim yj, kim js, kim jt, kim mh, kim jh. Int J Oncol. 2006 Jan;28(1):53-9. Int J Oncol. 2006. PMID: 16327979

4

Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.

Son MJ, Song HS, Kim MH, Kim JT, Kang CM, Jeon JW, Park SY, Kim YJ, Groves MD, Park K, Kim JH, Nam DH. Son MJ, et al. Among authors: kim yj, kim jt, kim mh, kim jh. Int J Oncol. 2006 Jun;28(6):1385-92. Int J Oncol. 2006. PMID: 16685440

5

Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.

Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH. Kim JT, et al. Among authors: kim js, kim mh. Oncol Rep. 2006 Jul;16(1):33-9. Oncol Rep. 2006. PMID: 16786120

6

Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model.

Choi YJ, Nam SJ, Son MJ, Kim DK, Kim JH, Yang JH, Kim MH, Song HS, Nam DH, Bang SI. Choi YJ, et al. Among authors: kim dk, kim mh, kim jh. Oncol Rep. 2006 Jul;16(1):119-22. Oncol Rep. 2006. PMID: 16786133

7

Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor.

Joo KM, Park K, Kong DS, Song SY, Kim MH, Lee GS, Kim MS, Nam DH. Joo KM, et al. Among authors: kim ms, kim mh. Oncol Rep. 2008 Jan;19(1):17-23. Oncol Rep. 2008. PMID: 18097571

8

The progression of gliomas is associated with cancer stem cell phenotype.

Kong DS, Kim MH, Park WY, Suh YL, Lee JI, Park K, Kim JH, Nam DH. Kong DS, et al. Among authors: kim mh, kim jh. Oncol Rep. 2008 Mar;19(3):639-43. Oncol Rep. 2008. PMID: 18288395

9

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, Jeon JW, Kim MH, Kang BG, Jung Y, Jin J, Hong SC, Park WY, Lee DS, Kim H, Nam DH. Joo KM, et al. Among authors: kim h, kim sy, kim mh. Lab Invest. 2008 Aug;88(8):808-15. doi: 10.1038/labinvest.2008.57. Epub 2008 Jun 16. Lab Invest. 2008. PMID: 18560366 Free article.

10

Activation of notch signaling in a xenograft model of brain metastasis.

Nam DH, Jeon HM, Kim S, Kim MH, Lee YJ, Lee MS, Kim H, Joo KM, Lee DS, Price JE, Bang SI, Park WY. Nam DH, et al. Among authors: kim h, kim s, kim mh. Clin Cancer Res. 2008 Jul 1;14(13):4059-66. doi: 10.1158/1078-0432.CCR-07-4039. Clin Cancer Res. 2008. PMID: 18593982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,632 results

Search Page

Filters